Natco, Eris Life to launch slimming shots in both Vial and Pen formats

Natco Pharma and Eris Lifesciences are launching generic semaglutide weight-loss injections. The companies are introducing both vial and pen formats. This move aims to make the treatment more affordable. Vials will be available first, targeting a wider patient base. Pens are expected later for metropolitan markets. This strategy offers patients pricing flexibility.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wPXzTLW
via IFTTT